Search

everythinglearnresearchcommunity

for

Search:↓

Gut health affects skin diseases, and probiotics might help.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Stem cell serum effectively treated hair loss caused by COVID-19.

Long COVID has severely affected a couple's health, finances, and social life.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

COVID-19 can cause significant hair loss.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Social media data can help track and predict COVID-19 symptoms and trends.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.